InChI=1S/C25H42N2O19/c1- 7(30) 26- 13- 9(32) 3- 25(24(40) 41,46- 21(13) 15(34) 10(33) 4- 28) 42- 6- 12- 16(35) 18(37) 19(38) 23(44- 12) 45- 20- 11(5- 29) 43- 22(39) 14(17(20) 36) 27- 8(2) 31/h9- 23,28- 29,32- 39H,3- 6H2,1- 2H3,(H,26,30) (H,27,31) (H,40,41) /t9- ,10+,11+,12+,13+,14+,15+,16- ,17+,18- ,19+,20+,21+,22+,23- ,25+/m0/s1 |
RPSBVJXBTXEJJG-LURNZOHQSA-N |
[H] [C@] 1(O[C@@] (C[C@H] (O) [C@H] 1NC(C) =O) (OC[C@H] 1O[C@@H] (O[C@H] 2[C@H] (O) [C@@H] (NC(C) =O) [C@H] (O) O[C@@H] 2CO) [C@H] (O) [C@@H] (O) [C@H] 1O) C(O) =O) [C@H] (O) [C@H] (O) CO |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
|
|
5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→6)- β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- β- D- glucopyranose
|
(2R,4S,5R,6R)- 5- acetamido- 2- {[(2R,3R,4S,5R,6S)- 6- {[(2R,3S,4R,5R,6R)- 5- acetamido- 4,6- dihydroxy- 2- (hydroxymethyl)oxan- 3- yl]oxy}- 3,4,5- trihydroxyoxan- 2- yl]methoxy}- 4- hydroxy- 6- [(1R,2R)- 1,2,3- trihydroxypropyl]oxane- 2- carboxylic acid
|
HMDB
|
(N-acetylneuraminosyl(alpha2-6)lactosamine)
|
HMDB
|
6'-Sialyllactosamine
|
HMDB
|
6-Sialyllactosamine
|
ChemIDplus
|
alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
|
ChEBI
|
alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
|
KEGG COMPOUND
|
alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
|
HMDB
|
alpha-N-Acetylneuraminyl-2,6-beta-delta-galactosyl-1,4-N-acetyl-beta-delta-glucosamine
|
HMDB
|
α-NeuNAc-(2→6)-β-D-Gal-(1→4)-β-D-GlcNAc
|
ChEBI
|
α- NeupNAc- (2→6)- β- D- Galp- (1→4)- β- D- GlcpNAc
|
ChEBI
|
N-Acetylneuraminosyl(alpha2-6)lactosamine
|
ChemIDplus
|
Neu5Aca2-6Galb1-4GlcNAcb
|
ChEBI
|
Neuac-lact
|
ChemIDplus
|
NeuAcalpha2,6Galbeta1,4GlcNAc
|
HMDB
|
Neuacalpha2,6GalNAcbeta1,4GlcNAc
|
ChemIDplus
|
Neuacalpha2-6Galbeta1-4GlcNAcbeta
|
ChemIDplus
|
O- (N- Acetyl- a- neuraminosyl)- (2→6)- O- b- D- galactopyranosyl- (1→4)- 2- (acetylamino)- 2- deoxy- b- D- Glucopyranose
|
HMDB
|
O- (N- Acetyl- alpha- neuraminosyl)- (26)- O- beta- D- galactopyranosyl- (1→- 4)- 2- (acetylamino)- 2- deoxy- beta- D- Glucopyranose
|
HMDB
|
O- (N- Acetyl- alpha- neuraminosyl)- (2→6)- O- beta- delta- galactopyranosyl- (1→- 4)- 2- (acetylamino)- 2- deoxy- beta- delta- Glucopyranose
|
HMDB
|
O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→6)- O- β- D- galactopyranosyl- (1→4)- 2- (acetylamino)- 2- deoxy- β- D- glucopyranose
|
ChEBI
|
WURCS=2.0/3,3,2/[a2122h- 1b_1- 5_2*NCC/3=O][a2112h- 1b_1- 5][Aad21122h- 2a_2- 6_5*NCC/3=O]/1- 2- 3/a4- b1_b6- c2
|
GlyTouCan
|
5721087
|
Beilstein Registry Number
|
Beilstein
|
64364-50-7
|
CAS Registry Number
|
ChemIDplus
|